← Back to Search

Behavioral Intervention

Penn Med Healthy Heart Program for High Blood Pressure

N/A

Recruiting

Led By Kevin Volpp, MD, PhD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6-month period

Awards & highlights

Study Summary

This trial aims to use technology to identify eligible patients in primary care clinics and enroll them in a program aimed at changing patient behavior to improve blood pressure and cholesterol levels over a 6-month period. The

Who is the study for?

This trial is for Penn Medicine patients in West/Southwest Philadelphia and Lancaster with high blood pressure or cholesterol. Eligible participants may have heart disease, a risk score of ≥10%, diabetes, an A1c level ≥6.5, or LDL levels ≥190 within the past five years. They must not be on certain cholesterol medications and have had high systolic blood pressure readings recently.Check my eligibility

What is being tested?

The trial tests the Penn Med Healthy Heart Program aimed at changing patient behavior to improve blood pressure and cholesterol over six months using EPIC tools for patient identification and the Way to Health platform for program enrollment.See study design

What are the potential side effects?

Since this intervention focuses on lifestyle modification rather than medication, side effects are minimal but can include discomfort from changes in diet or exercise routines.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6-month period

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6-month period

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-month period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Difference in mean LDL-c

Difference in mean Systolic Blood Pressure (SBP)

Secondary outcome measures

Difference in Diastolic Blood Pressure (DBP)

Engagement in the BP intervention

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Penn Med Healthy Heart ProgramExperimental Treatment1 Intervention

The Intervention group will receive the blood pressure monitor and move through the 4 HDPP modules of the intervention.

Group II: Usual CareActive Control1 Intervention

This group will not receive the intervention and will continue with usual care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,005 Previous Clinical Trials

42,880,307 Total Patients Enrolled

Kevin Volpp, MD, PhDPrincipal InvestigatorUniversity of Pennsylvania

16 Previous Clinical Trials

385,581 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any ongoing opportunities for patients to participate in this medical study?

"Per clinicaltrials.gov, this investigation is presently in search of potential participants. It was initially disclosed on March 11th, 2024, and most recently revised on March 18th, 2024."

Answered by AI

What is the upper limit in terms of patient enrollment for this medical study?

"Indeed, the details on clinicaltrials.gov indicate that this medical trial is presently enrolling subjects. The study was initially posted on March 11th, 2024 and most recently revised on March 18th, 2024. Recruitment aims to enlist a total of 1800 patients from one designated site."

Answered by AI

Is the clinical trial open to individuals who have reached adulthood?

"Candidates must be between 35 and 80 years old to qualify for participation in this research study."

Answered by AI

Which individuals are eligible to partake in this research investigation?

"Individuals with hypertension aged between 35 and 80 are eligible for inclusion in this research project, which aims to enroll approximately 1800 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Penn Medicine Healthy Heart

2024. "Penn Medicine Healthy Heart". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06062394.